Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Taubert medicin AB
AB
Active
Org 5590211883
Lupingränd 17, 135 37
Tyresö
General medical practice activities
·
NACE 8621
Est. 2015 · 11 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
General medical practice activities
/
Taubert medicin AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2022: 0M
0M
2022
2023: 1M
1M
2023
2024: 2M (+100% vs 2023)
2M
+100%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
2026: 1M
1M
2026
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
2026: 0M
0M
2026
Income statement
SEK thousands
Item
2026
2025
2024
2023
2022
Revenue
520
404
1 859
1 055
202
Staff expenses
−286
−338
−1 535
−876
−208
EBITDA
144
1
130
34
−74
Depreciation & amort.
—
—
—
—
—
EBIT
144
1
130
34
−74
Net financials
0
−1
−0
−0
—
Profit before tax
145
−0
130
33
−74
Tax
−30
−0
−19
—
—
Net profit
115
−0
111
33
−74
Balance sheet
SEK thousands
Item
2026
2025
2024
2023
2022
Total assets
239
97
421
293
129
Equity
165
54
164
63
30
Long-term debt
—
0
6
18
—
Short-term debt
74
43
250
213
99
Total debt
74
43
256
230
99
Financial ratios
5-year trend
EBITDA margin
27,8 %
This company
15,8 %
Market median
This company
Market median
76% above market
2022
2026
Equity ratio
69,1 %
This company
38,2 %
Market median
This company
Market median
81% above market
2022
2026
Return on equity
69,6 %
This company
18,4 %
Market median
This company
Market median
278% above market
2022
2026
Net profit margin
22,1 %
This company
8,1 %
Market median
This company
Market median
173% above market
2022
2026
Asset turnover
2,18×
This company
1,12×
Market median
This company
Market median
95% above market
2022
2026
Debt / equity
0,45×
This company
0,62×
Market median
This company
Market median
27% below market
2022
2026
Annual reports & filings
Annual report 2026
Filed via Bolagsverket / SCB · Period 2025-05-01 – 2026-04-30
View
PDF
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
More on Taubert medicin AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
